Genetic Leap
Genetic Leap is a biotechnology company innovating at the intersection of AI and RNA genetic medicine to transform drug development. Their proprietary AI platform enables precise targeting and modulation of RNA at the sequence and structural levels using oligonucleotides and small molecules, offering a novel approach to treat diseases by intervening at the RNA dimension. The company addresses the limitations of traditional protein-targeted therapies by leveraging whole genome analysis and genetics-aware AI to identify causal disease factors and develop effective, convenient, and safe RNA-targeted drugs. Genetic Leap has established significant collaborations with major pharmaceutical companies such as Eli Lilly and Astellas, demonstrating traction and validation in the field. Their business model centers on AI-driven drug discovery and development partnerships, aiming to accelerate the creation of genetic medicines for complex diseases like cancer and beyond.
Genetic Leap
Genetic Leap is a biotechnology company innovating at the intersection of AI and RNA genetic medicine to transform drug development. Their proprietary AI platform enables precise targeting and modulation of RNA at the sequence and structural levels using oligonucleotides and small molecules, offering a novel approach to treat diseases by intervening at the RNA dimension. The company addresses the limitations of traditional protein-targeted therapies by leveraging whole genome analysis and genetics-aware AI to identify causal disease factors and develop effective, convenient, and safe RNA-targeted drugs. Genetic Leap has established significant collaborations with major pharmaceutical companies such as Eli Lilly and Astellas, demonstrating traction and validation in the field. Their business model centers on AI-driven drug discovery and development partnerships, aiming to accelerate the creation of genetic medicines for complex diseases like cancer and beyond.